EUVIMEDEUVIMED entdecken
Crossref

Skin-resident CXCR6+ memory CD4+ T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis

Ryota Asahina, Fuuka Minami, Satoshi Nakamizo, Toshiya Miyake, Satoru Yonekura, Toshiaki Kogame, Shuto Kanameishi, Kosuke Katsuo, Hiroyuki Irie, Saeko Nakajima, Takashi Nomura, Akihiko Kitoh und 2 weitere

Immunity · 2026-11 · 59 (11) · 2992-3007.e5

DOI: 10.1016/j.immuni.2026.09.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2026-11. Verfasst von Ryota Asahina und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Center for One Medicine Innovative Translational Research (COM…. Hauptthemen laut MEDLINE: Receptors, CXCR6, Dermatitis, Atopic, CD4-Positive T-Lymphocytes, Skin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, LEO Fondet, Shimizu Foundation for Immunology and Neuroscience.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD4+ tissue-resident memory T (TRM) cells are crucial for relapse in allergic skin conditions. However, the mechanisms underlying their maintenance and pathogenic potential remain poorly defined. Here, across multiple models of allergic dermatitis, we identified a C-X-C chemokine receptor 6 (CXCR6+) subpopulation within CD4+ TRM cells as a distinct pathogenic subset that rapidly induces relapse. This subset is supported by C-X-C chemokine ligand 16 (CXCL16)-dependent interactions with CD301b+ conventional type 2 dendritic cells (cDC2s) for in situ maintenance. Functional blockade of the CXCL16-CXCR6 signaling pathway impaired proliferation and maintenance of CXCR6+ CD4+ TRM cells. In human atopic dermatitis (AD), CXCR6+ CD4+ TRM cells co-localized with CD301+ cDC2s in perivascular clusters even after successful anti-IL-13 therapy. These findings point to CXCR6+ CD4+ TRM cells as a pathogenic reservoir sustaining chronic and recurrent inflammation and suggest the CXCL16-CXCR6 axis as a therapeutic target to prevent relapse in allergic skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR6Dermatitis, AtopicCD4-Positive T-LymphocytesSkinDendritic CellsMemory T CellsAnimalsHumansChemokine CXCL16MiceImmunologic MemoryRecurrenceMice, Inbred C57BLSignal TransductionMice, KnockoutFemaleDisease Models, Animal

Stichwörter der Autor:innen

CD4(+) tissue-resident memory T cellsCXCL16CXCR6T cell-dendritic cell interactionsallergic skin disease relapseatopic dermatitisconventional type 2 dendritic cellspathogenic TRM subsetperivascular clusters

Substanzen

Receptors, CXCR6Chemokine CXCL16Cxcr6 protein, mouseCXCR6 protein, humanCxcl16 protein, mouse

Autor:innen und Institutionen

  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Center for One Medicine Innovative Translational Research (COMIT), Institute for Advanced Study, Gifu University, Gifu, Japan. Elect…
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Alliance Laboratory for Advanced Medical Research, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Drug Discovery for Inflammatory Skin Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Drug Discovery for Intractable Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Dermatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • LEO Fondet
  • Shimizu Foundation for Immunology and Neuroscience
  • Japan Society for the Promotion of Science
  • Fujiwara Memorial Foundation
  • Cosmetology Research Foundation

Zitieren

APA

Asahina, R., Minami, F., Nakamizo, S., Miyake, T., Yonekura, S., Kogame, T., Kanameishi, S., Katsuo, K., Irie, H., Nakajima, S., Nomura, T., Kitoh, A., Egawa, G., & Kabashima, K. (2026). Skin-resident CXCR6+ memory CD4+ T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis. Immunity, 59(11), 2992-3007.e5. https://doi.org/10.1016/j.immuni.2026.09.010

Vancouver

Asahina R, Minami F, Nakamizo S, Miyake T, Yonekura S, Kogame T, et al. Skin-resident CXCR6+ memory CD4+ T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis. Immunity. 2026;59(11):2992-3007.e5. doi:10.1016/j.immuni.2026.09.010

BibTeX
@article{Asahina2026,
  author = {Asahina, Ryota and Minami, Fuuka and Nakamizo, Satoshi and Miyake, Toshiya and Yonekura, Satoru and Kogame, Toshiaki and Kanameishi, Shuto and Katsuo, Kosuke and Irie, Hiroyuki and Nakajima, Saeko and Nomura, Takashi and Kitoh, Akihiko and Egawa, Gyohei and Kabashima, Kenji},
  title = {Skin-resident CXCR6+ memory CD4+ T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis},
  journal = {Immunity},
  year = {2026},
  volume = {59},
  number = {11},
  pages = {2992--3007.e5},
  doi = {10.1016/j.immuni.2026.09.010}
}
Kostenlos starten →